Article: Clinigen acquires distribution rights to nabilone.

Clinigen Healthcare, a UK firm that sources and supplies named-patient unlicensed medicinal products, has acquired the distribution rights to Cesamet (nabilone), a cannabinoid drug for treating patients with chemotherapy-induced nausea and vomiting who fail to respond ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!